China Pharmaceutical and Health Industry Co., Ltd., founded in 1984, is a comprehensive enterprise dedicated to the development of pharmaceutical industry and human health, integrating drug research and development, planting and processing, production, import and export trade, etc
China National Pharmaceutical and Health Industry Co., Ltd. is a state-controlled listed company listed on the Shanghai Stock Exchange (stock abbreviation: China National Pharmaceutical; Stock code: 600056), its controlling shareholder is China General Technology (Group) Holding Co., Ltd., a central backbone enterprise. Adhering to the core concept of "caring for life and pursuing excellence", the company is committed to the development of the pharmaceutical industry and human health, and strives to build a flagship enterprise in the field of medicine in China.
The company has established an integrated industrial pattern of science, industry and trade led by international trade, supported by the pharmaceutical industry and linked by pharmaceutical business, and the industrial form involves the whole industrial chain of research and development, planting and processing, production, distribution, logistics, import and export trade, academic promotion, and technical services.
In the field of pharmaceutical R&D and production, the company has two post-doctoral research stations and a large number of high-quality R&D experts, and has won the second prize of the National Science and Technology Progress Award; The company has a leading R&D and production platform for chemical raw materials in China, an advanced R&D and production platform for characteristic chemical drugs and modern Chinese medicine in China, and is in a leading position in the R&D and production of anti-infective and antiviral drugs, as well as the planting and processing of licorice and other medicinal materials and their products.
In the field of international trade, as the main traditional professional channel in the import and export field of the pharmaceutical industry, the company has always maintained a leading position, and has traditional strength and characteristic advantages in the field of government project business. The natural medicine trading business adheres to the professional development model of the whole industry chain, organically integrates the industrial chain links such as natural medicine planting, warehousing, processing and sales, and occupies a leading position in the industry. The business scope of pharmaceutical and chemical trade covers all specifications and fields of chemical raw materials and preparations, biological and blood products, and can provide customers with first-class integrated services for pharmaceutical and chemical trade. The medical device trading business is committed to providing customers with whole-process project integration services, and has established a solid cooperative relationship with the world's famous medical device manufacturers, and is in a leading position in the field of import and distribution. The bulk commodity business in the health field involves health food raw materials, bulk agricultural products, fine chemical raw materials, etc., and has a high reputation in the import and export trade of some key commodities.
In the field of domestic pharmaceutical business, the company has gradually established a pharmaceutical business system with high-end and characteristic products as the core and synergistic advantages of industrial value chain integration. It has formed a marketing network system focusing on Beijing, Guangdong, Jiangxi, Henan, Hebei, Hubei and Xinjiang, covering the whole country, and has a high reputation and brand influence in the region. The company has built a large-scale logistics center, with perfect business qualifications, and can provide a full range of value-added services for the majority of partners.
Facing the future, China National Pharmaceutical Co., Ltd. will focus on establishing a marketing network across the domestic and international markets in key product areas, focusing on core industries such as modern traditional Chinese medicine, characteristic chemical preparations and biopharmaceuticals, building an industrial chain integrating R&D, production, sales and service, and striving to develop the company into a large-scale pharmaceutical enterprise group integrating science, industry and trade with an important position in the domestic pharmaceutical industry and strong competitiveness and brand influence in the international market.
